https://pittplusme.org/study/1473
Falcon 1 Study
We're sorry. This study is closed and no longer recruiting participants.
STUDY BASICS
Have you been diagnosed with Nonalcoholic Steatohepatitis (NASH) and stage 3 liver fibrosis? If so, you may be eligible to participate in a study to help researchers find out how effective and how safe a study drug, called BMS-986036, is in reducing the liver damage caused by NASH. Involves up to 16 visits. Travel reimbursement is provided.
IRB: SSU00075210
- MB130-068, A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of BMS-986036 (PEG-FGF21) in Adults with Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis (Pro00025787)
AGE:
18 - 75
VISITS:
16 visits
LOCATION:
UPMC Montefiore Hospital - Oakland
COMPENSATION:
Up to $800.00 for completing all visits and procedures
SHARE STUDY
